Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Therapeutic Advances in Drug Safety|November 2, 2017
Gastrointestinal adverse effects of cyclin-dependent kinase 4 and 6 inhibitors in breast cancer patients: a systematic review and meta-analysisKyrillus S Shohdy, Shaimaa Lasheen, Loay Kassem, et al.JCO Global Oncology|September 3, 2025
Social Determinants Associated With the Advanced-Stage Diagnosis of Breast CancerMadonna A Fekry, Loay Kassem, Justin C Yang, et al.Breast Cancer (Tokyo, Japan)|November 18, 2017
Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysisLoay Kassem, Kyrillus S Shohdy, Shaimaa Lasheen, et al.Bulletin Du Cancer|June 30, 2015
[Advanced luminal breast cancer (hormone receptor-positive, HER2 negative): New therapeutic options in 2015]Hélène Vanacker, Olivia Bally, Loay Kassem, et al.The Breast Journal|November 12, 2019
Understanding the benefits and challenges of first-line cyclin-dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal womenHamdy A Azim, Shaheenah Dawood, Nagi El-Saghir, et al.Current Problems in Cancer|June 13, 2020
Adjuvant ovarian function suppression and tamoxifen in premenopausal breast cancer patients: A meta-analysisHamdy A Azim, Kyrillus S Shohdy, David F Kaldas, et al.International Journal of Breast Cancer|November 18, 2020
Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future PerspectivesKarima Oualla, Loay Kassem, Lamiae Nouiakh, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 18, 2022
Programmed death-ligand 1 (PD-L1) expression predicts response to neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysisHamdy A Azim, Kyrillus S Shohdy, Hagar Elghazawy, et al.Critical Reviews in Oncology/Hematology|February 18, 2019
Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic reviewLoay Kassem, Kyrillus S Shohdy, Shaimaa Lasheen, et al.Journal of Breast Cancer|April 4, 2019
Durable Response of Androgen Receptor-Positive Male Breast Cancer to GoserelinHamdy Abdel Azim, Loay Kassem, Kyrillus Samaan Shohdy, et al.Pageof 5